Skip to Content
Merck
CN
  • Protocol for determining the regulation of lipid kinases and changes in phospholipids in vitro.

Protocol for determining the regulation of lipid kinases and changes in phospholipids in vitro.

STAR protocols (2021-11-13)
Cansu Karabiyik, David C Rubinsztein
ABSTRACT

The regulation of lipid kinases has remained elusive given the difficulties of assessing changes in lipid levels. Here, we describe the isolation of protein and lipid kinases to determine the regulation of lipid kinases in vitro. This can be followed by analysis of effects of regulators on lipid kinase-mediated changes in phospholipids without the use of radioactivity, with a specific focus on PI(5)P generation by the enzyme PIKfyve. For complete details on the use and execution of this protocol, please refer to Karabiyik et al. (2021).

MATERIALS
Product Number
Brand
Product Description

Sigma-Aldrich
Phosphatase Inhibitor Cocktail 3, DMSO solution
Sigma-Aldrich
Phosphatase Inhibitor Cocktail 2, aqueous solution (dark coloration may develop upon storage, which does not affect the activity)
Sigma-Aldrich
SBI-0206965, ≥98% (HPLC)